CysBio ApS — Credit Rating and Financial Key Figures
CVR number: 40270752
Agern Alle 1, 2970 Hørsholm
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | -2 058.32 | 8 047.45 | -6 310.97 | 5 417.52 | -5 720.84 |
Employee benefit expenses | -4 270.56 | -7 036.80 | -9 996.00 | -9 905.60 | -11 243.29 |
Total depreciation | - 243.72 | - 991.52 | -1 009.62 | -1 070.01 | -1 013.01 |
EBIT | -6 572.60 | 19.14 | -17 316.58 | -5 558.09 | -17 977.13 |
Other financial income | 0.01 | 0.26 | 1.81 | 19.89 | 265.16 |
Other financial expenses | -31.93 | -45.69 | - 214.59 | - 188.53 | -31.91 |
Pre-tax profit | -6 604.53 | -26.29 | -17 529.37 | -5 726.73 | -17 743.88 |
Income taxes | 1 452.97 | 5.78 | 3 851.35 | 1 245.42 | 3 894.40 |
Net earnings | -5 151.56 | -20.51 | -13 678.02 | -4 481.31 | -13 849.48 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Machinery and equipment | 3 905.50 | 3 598.35 | 2 857.67 | 1 896.35 | 1 015.91 |
Tangible assets total | 3 905.50 | 3 598.35 | 2 857.67 | 1 896.35 | 1 015.91 |
Investments total | |||||
Non-current other receivables | 194.86 | 272.48 | 464.76 | 476.50 | 524.33 |
Long term receivables total | 194.86 | 272.48 | 464.76 | 476.50 | 524.33 |
Inventories total | |||||
Current trade debtors | 5 041.90 | ||||
Current amounts owed by group member comp. | 2 649.38 | ||||
Prepayments and accrued income | 66.59 | 180.75 | 320.05 | 194.27 | 201.17 |
Current other receivables | 873.77 | 383.20 | 3 947.28 | 865.02 | 677.53 |
Current deferred tax assets | 1 452.97 | 67.95 | 509.18 | 1 754.60 | 4 643.50 |
Short term receivables total | 2 393.33 | 631.91 | 4 776.51 | 7 855.78 | 8 171.57 |
Cash and bank deposits | 12 738.95 | 33 542.93 | 16 140.30 | 17 711.78 | 13 320.71 |
Cash and cash equivalents | 12 738.95 | 33 542.93 | 16 140.30 | 17 711.78 | 13 320.71 |
Balance sheet total (assets) | 19 232.64 | 38 045.67 | 24 239.24 | 27 940.41 | 23 032.52 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 80.00 | 92.31 | 92.31 | 92.31 | 92.31 |
Share premium account | 22 318.30 | 40 773.70 | 40 773.70 | 40 773.70 | 40 773.70 |
Retained earnings | -5 151.56 | -5 172.07 | -18 850.09 | -23 331.40 | |
Profit of the financial year | -5 151.56 | -20.51 | -13 678.02 | -4 481.31 | -13 849.48 |
Shareholders equity total | 17 246.74 | 35 693.94 | 22 015.92 | 17 534.61 | 3 685.12 |
Non-current advances received | 8 761.45 | 17 535.02 | |||
Non-current liabilities total | 8 761.45 | 17 535.02 | |||
Current bonds | 457.80 | 664.48 | |||
Current trade creditors | 1 320.53 | 505.35 | 910.22 | 1 186.55 | 1 147.90 |
Other non-interest bearing current liabilities | 665.37 | 1 846.38 | 1 313.10 | ||
Current liabilities total | 1 985.90 | 2 351.73 | 2 223.32 | 1 644.35 | 1 812.38 |
Balance sheet total (liabilities) | 19 232.64 | 38 045.67 | 24 239.24 | 27 940.41 | 23 032.52 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.